BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15269051)

  • 1. Diffuse splenic metastases from seminoma visualized on FDG PET.
    Lenzo NP; Moschilla G; Patrikeos A
    AJR Am J Roentgenol; 2004 Aug; 183(2):525-7. PubMed ID: 15269051
    [No Abstract]   [Full Text] [Related]  

  • 2. Late relapse of testicular seminoma in the posterior mediastinum.
    Shin DJ; Kim JS; Kim DY; Yeo JS
    Clin Imaging; 2013; 37(2):406-8. PubMed ID: 23466004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of relapsed testicular cancer initially isolated to the spleen.
    Moore AM; Simon SR; Einhorn LH
    Am J Clin Oncol; 2009 Dec; 32(6):639. PubMed ID: 19955902
    [No Abstract]   [Full Text] [Related]  

  • 4. False-positive finding in FDG-PET in a patient with seminoma and sarcoidosis.
    Liepe K
    Acta Clin Belg; 2015 Apr; 70(2):138-40. PubMed ID: 25409626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serendipitous detection of testicular seminoma on F-18 FDG positron tomography.
    Ali I; Johns W; Bottger B; Gupta SM
    Clin Nucl Med; 2007 Mar; 32(3):201-2. PubMed ID: 17314595
    [No Abstract]   [Full Text] [Related]  

  • 6. 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.
    De Santis M; Becherer A; Bokemeyer C; Stoiber F; Oechsle K; Sellner F; Lang A; Kletter K; Dohmen BM; Dittrich C; Pont J
    J Clin Oncol; 2004 Mar; 22(6):1034-9. PubMed ID: 15020605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET for detection and therapy control of metastatic germ cell tumor.
    Cremerius U; Effert PJ; Adam G; Sabri O; Zimmy M; Wagenknecht G; Jakse G; Buell U
    J Nucl Med; 1998 May; 39(5):815-22. PubMed ID: 9591582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorodeoxyglucose PET in the initial staging of germ cell tumours.
    Hain SF; O'Doherty MJ; Timothy AR; Leslie MD; Partridge SE; Huddart RA
    Eur J Nucl Med; 2000 May; 27(5):590-4. PubMed ID: 10853816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S80-7. PubMed ID: 12739339
    [No Abstract]   [Full Text] [Related]  

  • 10. 18F-FDG PET/CT with unusual bone and CNS metastases from testicular seminoma.
    Gómez FJ; Bánez IA; González RL; Jiménez-Granero P; Dorado IB
    Int Braz J Urol; 2015; 41(2):393-4. PubMed ID: 26005986
    [No Abstract]   [Full Text] [Related]  

  • 11. 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma.
    Rini JN; Leonidas JC; Tomas MB; Palestro CJ
    J Nucl Med; 2003 Jul; 44(7):1072-4. PubMed ID: 12843223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
    Hain SF; O'Doherty MJ; Timothy AR; Leslie MD; Harper PG; Huddart RA
    Br J Cancer; 2000 Oct; 83(7):863-9. PubMed ID: 10970686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
    Pfannenberg AC; Oechsle K; Kollmannsberger C; Dohmen BM; Bokemeyer C; Bares R; Vontheim R; Claussen CD
    Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluorodeoxyglucose (FDO) positron emission tomography (PET) in testicular germ cell tumors in adults: preliminary French clinical evaluation, development of the technique and its clinical applications].
    Maszelin P; Lumbroso J; Theodore C; Foehrenbach H; Merlet P; Syrota A
    Prog Urol; 2000 Dec; 10(6):1190-9. PubMed ID: 11217558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: 18F-FDG PET/CT Impact on Testicular Tumours Clinical Management.
    Richie JP
    J Urol; 2015 Oct; 194(4):991. PubMed ID: 26382779
    [No Abstract]   [Full Text] [Related]  

  • 16. A pitfall of 18-fluorodeoxyglucose-PET in a patient with a tattoo.
    Nam H; Smith S; Laing R
    Lancet Oncol; 2007 Dec; 8(12):1147-1148. PubMed ID: 18054884
    [No Abstract]   [Full Text] [Related]  

  • 17. Caval seminoma thrombus on FDG PET/CT.
    Koc K; Aras M; Inanir S
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):64-5. PubMed ID: 24589250
    [No Abstract]   [Full Text] [Related]  

  • 18. Solitary splenic lymphoma detected with (18)F-FDG-PET/CT.
    Tamam M; Mulazimoglu M; Yavuz H; Aydin T; Filiz F; Ozpacaci T
    Hell J Nucl Med; 2011; 14(2):179-80. PubMed ID: 21761026
    [No Abstract]   [Full Text] [Related]  

  • 19. Seminoma and sarcoidosis: a cause for false positive mediastinal uptake in PET?
    Muggia FM; Conti PS
    Ann Oncol; 1998 Aug; 9(8):924. PubMed ID: 9789621
    [No Abstract]   [Full Text] [Related]  

  • 20. False positive 2-(18)Fluroro-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with disseminated seminoma and post-chemotherapy residual masses.
    Wagner M; Bellmunt J; Boutros C; Bonardel G; Loriot Y; Albiges L; Massard C; Fizazi K
    Clin Genitourin Cancer; 2013 Mar; 11(1):66-9. PubMed ID: 22981209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.